Teriflunomide Concentration in Serum and Cerebrospinal Fluid From Patients With Multiple Sclerosis
NCT04129736
·
clinicaltrials.gov ↗
PHASE4
Phase
COMPLETED
Status
12
Enrollment
OTHER
Sponsor class
Conditions
Multiple Sclerosis, Pharmacokinetics
Interventions
DRUG:
Teriflunomide 14 MG
Sponsor
Jan Lycke